178 related articles for article (PubMed ID: 21692989)
1. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau.
Usardi A; Pooler AM; Seereeram A; Reynolds CH; Derkinderen P; Anderton B; Hanger DP; Noble W; Williamson R
FEBS J; 2011 Aug; 278(16):2927-37. PubMed ID: 21692989
[TBL] [Abstract][Full Text] [Related]
2. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
[TBL] [Abstract][Full Text] [Related]
3. A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity.
Rush T; Roth JR; Thompson SJ; Aldaher AR; Cochran JN; Roberson ED
Neurobiol Dis; 2020 Feb; 134():104668. PubMed ID: 31698056
[TBL] [Abstract][Full Text] [Related]
4. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions.
Hock B; Böhme B; Karn T; Feller S; Rübsamen-Waigmann H; Strebhardt K
Oncogene; 1998 Jul; 17(2):255-60. PubMed ID: 9674711
[TBL] [Abstract][Full Text] [Related]
7. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
8. Disease-related modifications in tau affect the interaction between Fyn and Tau.
Bhaskar K; Yen SH; Lee G
J Biol Chem; 2005 Oct; 280(42):35119-25. PubMed ID: 16115884
[TBL] [Abstract][Full Text] [Related]
9. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.
Cochran JN; Diggs PV; Nebane NM; Rasmussen L; White EL; Bostwick R; Maddry JA; Suto MJ; Roberson ED
J Biomol Screen; 2014 Dec; 19(10):1338-49. PubMed ID: 25156556
[TBL] [Abstract][Full Text] [Related]
10. Fyn, a potential target for Alzheimer's disease.
Yang K; Belrose J; Trepanier CH; Lei G; Jackson MF; MacDonald JF
J Alzheimers Dis; 2011; 27(2):243-52. PubMed ID: 21799250
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions of protein tyrosine kinases, p59fyn and ZAP-70, in T cell signaling.
Fusaki N; Matsuda S; Nishizumi H; Umemori H; Yamamoto T
J Immunol; 1996 Feb; 156(4):1369-77. PubMed ID: 8568236
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity.
Choi S; Park S
Oncogene; 1999 Sep; 18(39):5413-22. PubMed ID: 10498895
[TBL] [Abstract][Full Text] [Related]
13. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
14. Fyn-induced phosphorylation of beta-adducin at tyrosine 489 and its role in their subcellular localization.
Gotoh H; Okumura N; Yagi T; Okumura A; Shima T; Nagai K
Biochem Biophys Res Commun; 2006 Jul; 346(2):600-5. PubMed ID: 16765915
[TBL] [Abstract][Full Text] [Related]
15. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts.
Hernandez P; Lee G; Sjoberg M; Maccioni RB
J Alzheimers Dis; 2009; 16(1):149-56. PubMed ID: 19158430
[TBL] [Abstract][Full Text] [Related]
16. Complexes of gamma-tubulin with nonreceptor protein tyrosine kinases Src and Fyn in differentiating P19 embryonal carcinoma cells.
Kukharskyy V; Sulimenko V; Macůrek L; Sulimenko T; Dráberová E; Dráber P
Exp Cell Res; 2004 Aug; 298(1):218-28. PubMed ID: 15242776
[TBL] [Abstract][Full Text] [Related]
17. Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current.
Jos S; Poulose R; Kambaru A; Gogoi H; Dalavaikodihalli Nanjaiah N; Padmanabhan B; Mehta B; Padavattan S
J Mol Biol; 2024 Feb; 436(4):168445. PubMed ID: 38218365
[TBL] [Abstract][Full Text] [Related]
18. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
19. The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions.
Feuillet V; Semichon M; Restouin A; Harriague J; Janzen J; Magee A; Collette Y; Bismuth G
Oncogene; 2002 Oct; 21(47):7205-13. PubMed ID: 12370810
[TBL] [Abstract][Full Text] [Related]
20. Dynamic association of tau with neuronal membranes is regulated by phosphorylation.
Pooler AM; Usardi A; Evans CJ; Philpott KL; Noble W; Hanger DP
Neurobiol Aging; 2012 Feb; 33(2):431.e27-38. PubMed ID: 21388709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
